TIDMCOS

RNS Number : 8445Y

Collagen Solutions PLC

24 August 2018

Collagen Solutions Plc

(the "Company" or the "Group")

Director/PDMR Dealing

The Company today announces that on 23 August 2018 Hilary Spence, Chief Financial Officer, purchased 220,000 Ordinary Shares at a purchase price of 4.50p.

Following these purchases, Hilary Spence holds 250,817 Ordinary Shares representing approximately 0.08 per cent of the Company's issued share capital.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

 
  1     Details of the person discharging managerial responsibilities / person closely associated 
  a)    Name                                                           Hilary Spence 
  2     Reason for the notification 
  a)    Position/status                                                Chief Financial Officer 
  b)    Initial notification / Amendment                               Initial 
  3     Details of the issuer, emission allowance market participant, auction platform, auctioneer 
         or auction monitor 
  a)    Name                                                           COLLAGEN SOLUTIONS PLC 
  b)    LEI                                                            213800IFY1CVGRGETL95 
  4     Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
         each type of transaction; (iii) each date; and (iv) each place where transactions have been 
         conducted 
  a)    Description of the financial instrument, type of instrument    Ordinary shares of 1p each 
 
         Identification code                                            ISIN: GB00B94T6Y14 
  b)    Nature of the transaction                                      Purchase of Ordinary Shares 
  c)    Price(s) and volume(s)                                           Price(s)            Volume(s) 
                                                                          4.50p per share     220,000 
  d)    Aggregated information 
         - Aggregated volume                                            N/A - single transaction 
         - Price 
  e)    Date of the transaction                                        23 August 2018 
  f)    Place of the transaction                                       London Stock Exchange, XLON

Enquiries:

 
 Collagen Solutions Plc 
 Jamal Rushdy, CEO                                                       Via Walbrook 
 Hilary Spence, CFO 
 
 Cenkos Securities Plc (Nominated 
  Adviser and Broker) 
 Steve Cox (Corporate Finance)                                     Tel: 0207 397 8900 
 Stephen Keys 
 
 Walbrook PR Ltd                        Tel: 020 7933 8780 or collagen@walbrookpr.com 
 Anna Dunphy                                                       Mob: 07876 741 001 
 Helen Cresswell                                                   Mob: 07841 917 679

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHFKQDQKBKDPFB

(END) Dow Jones Newswires

August 24, 2018 06:47 ET (10:47 GMT)

Collagen Solutions (LSE:COS)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Collagen Solutions Charts.
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Collagen Solutions Charts.